Belgium· BE-AMP-SAM504071-00

Enalapril/Lercanidipine Krka 10 mg - 10 mg

A enalapril und lercanidipin product containing lercanidipine hydrochloride, registered in Belgium by KRKA d.d. Novo mesto. The same ATC class is registered in 9 of our 19 countries.

ATC C09BB02

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about lercanidipine hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Enalapril und lercanidipin is registered in 9 of 19 countries.

Countries holding a registration under ATC C09BB02 (enalapril und lercanidipin), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
6 of them publish a price we can compare per daily dose

Search enalapril und lercanidipin products by name

Enalapril und lercanidipin · ATC C09BB02

9 / 19 countries

Belgiumprice
Denmark
Finlandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Lercanidipine Hydrochloride
Manufacturer: KRKA d.d. Novo mesto
Country: Belgium (BE)
ATC code: C09BB02
ATC class: Enalapril und Lercanidipin
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 4

1 priced

be_apb
3566965
EUR 14.32
be_apb
3566973
be_apb
7719495
be_apb
3597986

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

64 interactions on record for enalapril und lercanidipin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check enalapril und lercanidipin against other medicines How interaction checks work

Enalapril und lercanidipin · interactions on record

64 records

64 more interactions with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Enalapril und lercanidipin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All enalapril und lercanidipin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Lercanidipin Accord, Lercanidipin Actavis
Bulgaria · Areta, Арета
Cyprus · Zanedip
Czechia · Jospiten, Kapidin
Germany · Carmen, Corifeo
Denmark · Lercanidipine, Lercanidipine Accord
Estonia · Lercanidipine Accord, Lercanidipine Actavis
Spain · Lercadip, Lercanidipino Aurovitas Spain
Finland · Lercamed, Lercanidipin Hydrochlorid Actavis
France · Lercan, Lercanidipine Accord
United Kingdom (Northern Ireland) · Lercanidipine Generics [uk], Lercanidipine Hcl Recordati Industria Chimica E Farmaceutica S.P.A.
Greece · Lercadip, Zanidip
Croatia · Lercanil, Pinox
Hungary · Kapidin, Lecalpin
Ireland · Lecalpin, Lercanidipine Clonmel
Iceland · Lercanidipin Actavis, Lerkanidipin Actavis
Italy · Cardiovasc, Lercadip
Lithuania · Lercanidipine Actavis, Lercanidipine Ingen Pharma
Luxembourg · Lercanidipine Eg, Zanidip
Latvia · Kapidin, Lercanidipine Accord
Malta · Lercanidipine Torrent
Netherlands · Lercanidipine Accord, Lercanidipine Hcl Amarox
Norway · Lercanidipine Accord, Lercanidipine Orion
Poland · Jospiten, Kapizen
Portugal · Lercanidipina Alter, Lercanidipina Atral
Romania · Lercanidipină Gemax Pharma, Leridip
Sweden · Lercamed, Lercanidipine Accord
Slovenia · Lecalpin, Lercapress
Slovakia · Kapidin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ce98f2ce-1005-4f95-a425-6b3f467634a0
GET /v1/drugs/ce98f2ce-1005-4f95-a425-6b3f467634a0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Enalapril/Lercanidipine Krka 10 mg - 10 mg",
  "name_fr": "Enalapril/Lercanidipine Krka 10 mg - 10 mg",
  "name_nl": "Enalapril/Lercanidipine Krka 10 mg - 10 mg",
  "amp_code": "SAM504071-00",
  "strengths": [
    "10.0000",
    "9.4400",
    "10.0000",
    "7.6400",
    "317.0000",
    "40.0000",
    "8.0000"
  ],
  "pack_count": 12,
  "substances": [
    "Lercanidipine Hydrochloride",
    "Lercanidipine",
    "Enalapril Maleate",
    "Enalapril",
    "Lactose Monohydrate",
    "Sodium Starch Glycolate (Type A)",
    "Sodium Stearyl Fumarate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Enalapril and lercanidipine",
  "authorisation_numbers": [
    "BE504071"
  ]
}

API reference MCP server Plans

See everything about enalapril und lercanidipin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console